Metabolomics signatures of acutely ill and short-term weight recovered women with anorexia nervosa. 2021

Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Baronissi, Salerno, Italy. pmonteleone@unisa.it.

Although metabolomics studies are recently spreading and have allowed the characterization of putative biomarkers in many diseases, they are relatively scanty in anorexia nervosa (AN). In this explorative study we analyzed the fecal metabolomics profiles of women with AN in the underweight phase (n = 24) and after short-term weight restoration (n = 16) and compared them with 20 healthy women. An untargeted metabolomic procedure allowed the characterization of 224 metabolites involved in energy, lipid, and amino acid metabolism. A partial least square discriminant analysis identified 14 metabolites with a variable importance in projection score >1.5 that clearly differentiated underweight from weight-restored patients from healthy women. Compared with healthy women, fecal concentrations of valeric acid and 3-methyl,2-ketobutyric acid were increased in both underweight and weight-restored patients; fecal concentrations of propionic acid, stearic acid, linolenic acid, methyl-galactoside, coprosterol, cycloserine, and lauric acid were increased while fecal levels of xylose, fucose, and rhamnose were decreased in underweight patients and normalized after weight-restoration; fecal concentrations of piperine, phenylalanine, butyric acid, and meso-erythritol-1 were decreased while fecal levels of hydroxystearic acid were increased in weight-restored but normal in underweight AN patients. All these changes point to peculiar fecal metabolomics profiles of acute and short-term weight restored AN patients. The value of these changes to improve our understanding of the pathophysiology of AN and to characterize potential biomarker targets for developing new treatment strategies needs further studies to be clarified.

UI MeSH Term Description Entries
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000856 Anorexia Nervosa An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994) Anorexia Nervosas,Nervosa, Anorexia,Nervosas, Anorexia
D013851 Thinness A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards, such as BODY MASS INDEX, and dependent on age, sex, and genetic background. Leanness,Underweight
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D055432 Metabolomics The systematic identification and quantitation of all the metabolic products of a cell, tissue, organ, or organism under varying conditions. The METABOLOME of a cell or organism is a dynamic collection of metabolites which represent its net response to current conditions. Metabonomics,Metabolomic,Metabonomic

Related Publications

Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
March 2015, Psychoneuroendocrinology,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
April 2015, Psychological medicine,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
November 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
December 2012, Journal of psychiatric research,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
August 2010, Progress in neuro-psychopharmacology & biological psychiatry,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
January 2014, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
January 2015, Frontiers in behavioral neuroscience,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
June 1976, The Journal of endocrinology,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
September 2021, Journal of eating disorders,
Palmiero Monteleone, and Alessio Maria Monteleone, and Jacopo Troisi, and Riccardo Dalle Grave, and Giulio Corrivetti, and Simona Calugi, and Giovanni Scala, and Giuseppina Patriciello, and Adalgisa Zanetti, and Mario Maj
July 2008, Psychoneuroendocrinology,
Copied contents to your clipboard!